An Update on Clinical and Pathogenic Spectra of Leishmaniasis

Leishmaniasis, classified as a neglected tropical disease, exerts its impact on millions globally. Its clinical spectrum encompasses diverse forms, from benign self-resolving skin lesions (cutaneous leishmaniasis) to life-threatening visceral infections (visceral leishmaniasis or kala-azar). This re...

Full description

Saved in:
Bibliographic Details
Main Authors: Angamuthu Selvapandiyan, Shital Shital, Diya A’gitok Sangma, Manju Jain, Nadira Karunaweera, Nirmal K. Ganguly
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:Expert Reviews in Molecular Medicine
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S1462399425000043/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233074537103360
author Angamuthu Selvapandiyan
Shital Shital
Diya A’gitok Sangma
Manju Jain
Nadira Karunaweera
Nirmal K. Ganguly
author_facet Angamuthu Selvapandiyan
Shital Shital
Diya A’gitok Sangma
Manju Jain
Nadira Karunaweera
Nirmal K. Ganguly
author_sort Angamuthu Selvapandiyan
collection DOAJ
description Leishmaniasis, classified as a neglected tropical disease, exerts its impact on millions globally. Its clinical spectrum encompasses diverse forms, from benign self-resolving skin lesions (cutaneous leishmaniasis) to life-threatening visceral infections (visceral leishmaniasis or kala-azar). This review aims to comprehensively explore the spectrum of the disease as an outcome of often-overlooked parasite variants. Additionally, it addresses the emerging challenges faced in the pursuit towards disease elimination. The evolving landscape of leishmaniasis demands the development of molecular surveillance tools to detect the heterogeneous parasite strains that contribute to the emergence of new endemic foci. Such surveillance poses formidable challenges to current elimination strategies. As the disease landscape continues to evolve, understanding the molecular intricacies of causative parasite strains becomes paramount. This knowledge not only aids the understanding of the basis of emerging/shifting endemic areas but also facilitates the search for and the design of targeted interventions. In this context, this review will navigate through the dynamic terrain of leishmaniasis, the various causative species of Leishmania parasites emphasising the urgency for the development of robust surveillance mechanisms and innovative approaches to confront the evolving challenges in our quest for global disease elimination.
format Article
id doaj-art-d2fb39287c9a4eeb84f7424488b0a934
institution Kabale University
issn 1462-3994
language English
publishDate 2025-01-01
publisher Cambridge University Press
record_format Article
series Expert Reviews in Molecular Medicine
spelling doaj-art-d2fb39287c9a4eeb84f7424488b0a9342025-08-20T12:57:28ZengCambridge University PressExpert Reviews in Molecular Medicine1462-39942025-01-012710.1017/erm.2025.4An Update on Clinical and Pathogenic Spectra of LeishmaniasisAngamuthu Selvapandiyan0https://orcid.org/0000-0002-2194-1534Shital Shital1Diya A’gitok Sangma2Manju Jain3Nadira Karunaweera4Nirmal K. Ganguly5Department of Molecular Medicine, Jamia Hamdard University, New Delhi, IndiaDepartment of Molecular Medicine, Jamia Hamdard University, New Delhi, IndiaDepartment of Biochemistry, Central University of Punjab, Bathinda, IndiaDepartment of Biochemistry, Central University of Punjab, Bathinda, IndiaDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri LankaDepartment of Research, Sir Gangaram Hospital, New Delhi, IndiaLeishmaniasis, classified as a neglected tropical disease, exerts its impact on millions globally. Its clinical spectrum encompasses diverse forms, from benign self-resolving skin lesions (cutaneous leishmaniasis) to life-threatening visceral infections (visceral leishmaniasis or kala-azar). This review aims to comprehensively explore the spectrum of the disease as an outcome of often-overlooked parasite variants. Additionally, it addresses the emerging challenges faced in the pursuit towards disease elimination. The evolving landscape of leishmaniasis demands the development of molecular surveillance tools to detect the heterogeneous parasite strains that contribute to the emergence of new endemic foci. Such surveillance poses formidable challenges to current elimination strategies. As the disease landscape continues to evolve, understanding the molecular intricacies of causative parasite strains becomes paramount. This knowledge not only aids the understanding of the basis of emerging/shifting endemic areas but also facilitates the search for and the design of targeted interventions. In this context, this review will navigate through the dynamic terrain of leishmaniasis, the various causative species of Leishmania parasites emphasising the urgency for the development of robust surveillance mechanisms and innovative approaches to confront the evolving challenges in our quest for global disease elimination.https://www.cambridge.org/core/product/identifier/S1462399425000043/type/journal_articleclinical challengescutaneous leishmaniasisco-infectionsmolecular toolsmucocutaneous leishmaniasisvisceral leishmaniasis
spellingShingle Angamuthu Selvapandiyan
Shital Shital
Diya A’gitok Sangma
Manju Jain
Nadira Karunaweera
Nirmal K. Ganguly
An Update on Clinical and Pathogenic Spectra of Leishmaniasis
Expert Reviews in Molecular Medicine
clinical challenges
cutaneous leishmaniasis
co-infections
molecular tools
mucocutaneous leishmaniasis
visceral leishmaniasis
title An Update on Clinical and Pathogenic Spectra of Leishmaniasis
title_full An Update on Clinical and Pathogenic Spectra of Leishmaniasis
title_fullStr An Update on Clinical and Pathogenic Spectra of Leishmaniasis
title_full_unstemmed An Update on Clinical and Pathogenic Spectra of Leishmaniasis
title_short An Update on Clinical and Pathogenic Spectra of Leishmaniasis
title_sort update on clinical and pathogenic spectra of leishmaniasis
topic clinical challenges
cutaneous leishmaniasis
co-infections
molecular tools
mucocutaneous leishmaniasis
visceral leishmaniasis
url https://www.cambridge.org/core/product/identifier/S1462399425000043/type/journal_article
work_keys_str_mv AT angamuthuselvapandiyan anupdateonclinicalandpathogenicspectraofleishmaniasis
AT shitalshital anupdateonclinicalandpathogenicspectraofleishmaniasis
AT diyaagitoksangma anupdateonclinicalandpathogenicspectraofleishmaniasis
AT manjujain anupdateonclinicalandpathogenicspectraofleishmaniasis
AT nadirakarunaweera anupdateonclinicalandpathogenicspectraofleishmaniasis
AT nirmalkganguly anupdateonclinicalandpathogenicspectraofleishmaniasis
AT angamuthuselvapandiyan updateonclinicalandpathogenicspectraofleishmaniasis
AT shitalshital updateonclinicalandpathogenicspectraofleishmaniasis
AT diyaagitoksangma updateonclinicalandpathogenicspectraofleishmaniasis
AT manjujain updateonclinicalandpathogenicspectraofleishmaniasis
AT nadirakarunaweera updateonclinicalandpathogenicspectraofleishmaniasis
AT nirmalkganguly updateonclinicalandpathogenicspectraofleishmaniasis